LOGO
LOGO

Clinical Trial Calendar

Results Date
Company Name
Ticker
Event
Indication
Outcome
29-May-2026 To 02-Jun-2026
OS Therapies Inc.
2.5-year overall survival data of OST-HER2
Prevention or delay of recurrence in fully-resected, pulmonary metastatic osteosarcoma
31-May-2026
Agenus Inc.
Full data from Phase 2 study of botensilimab in combination with balstilimab (C-800-23)
Advanced cutaneous melanoma refractory or resistant to prior anti-PD-(L)1 therapy
04-Jun-2026
Zenas BioPharma, Inc.
Safety and efficacy results from Phase 3 trial of obexelimab (INDIGO)
Immunoglobulin G4-Related Disease (IgG4-RD)
25-Jun-2026 To 27-Jun-2026
Transgene SA
TRGNF, TNG.PA
Preclinical data of TG-MVA
mpox Vaccine